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Abstract
Corydalis plants containing isoquinoline alkaloids are reported to possess promising pharmacological
properties for the treatment of important diseases including cancer, inflammation, Alzheimer's disease and
microbial infections. As part of a wider program investigating Bhutanese medicinal plants, we have previously
identified eight isoquinoline alkaloids from C. dubia. Out of these, we report here on two of the major
alkaloids, scoulerine (1) and cheilanthifoline (2) and their inhibitory activities against acetylcholinesterase
(anti-AChE), tumor necrosis factor alpha (anti TNF-α) and a bacterial strain, Helicobacter pylori. Both
alkaloids showed weak anti TNF-α and antibacterial activities. However, the anti-AChE activity of scoulerine
(1) was promising as it significantly inhibited AChE with a minimum inhibitory requirement (MIR) value of
0.0015 nmol, which was two-fold better than the reference drug, galanthamine (MIR value of 0.003 nmol). As
there are limited anti-Alzheimer's chemotherapeutics, scoulerine (1) is worthy of further exploration,
including lead optimization, structure-activity-relationship studies, analog development, pharmacodynamics
and in vivo animal studies.
Keywords
alkaloids-scoulerine, activities, anti-acetylcholinesterase, anti-inflammatory, cheilanthifoline, isoquinoline,
anti-bacterial, two
Disciplines
Medicine and Health Sciences | Social and Behavioral Sciences
Publication Details
Wangchuk, P., Sastraruji, T., Taweechotipatr, M., Keller, P. A. & Pyne, S. G. (2016). Anti-inflammatory, anti-
bacterial and anti-acetylcholinesterase activities of two isoquinoline alkaloids-scoulerine and cheilanthifoline.
Natural Product Communications: an international journal for communications and reviews, 11 (12),
1801-1804.
This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/4508
 
Anti-inflammatory, Anti-bacterial and Anti-acetylcholinesterase  
Activities of two Isoquinoline Alkaloids–Scoulerine and Cheilanthifoline 
 
Phurpa Wangchuka,b*, Thanapat Sastrarujic, Malai Taweechotipatrd, Paul A Kellerb and Stephen G Pyneb 
 
aCenter for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health  
and Medicine, James Cook University, Cairns, QLD, Australia 
 
bSchool of Chemistry, University of Wollongong, Wollongong, NSW, 2522, Australia 
 
cCenter of Excellence in Oral and Maxillofacial Biology, Department of Oral Biology and Diagnostic Sciences, 
Faculty of Dentistry, Chiang Mai University, Thailand 
 
dDepartment of Microbiology, Faculty of Medicine, Srinakharinwirot University, Sukhumvit 23, Bangkok 10110,  
Thailand 
 
phurpaw@yahoo.com 
 
 
Received: February 23rd, 2016; Accepted: XX, 2016 
 
 
 
Corydalis plants containing isoquinoline alkaloids are reported to possess promising pharmacological properties for the treatment of important diseases 
including cancer, inflammation, Alzheimer’s disease and microbial infections. As part of a wider program investigating Bhutanese medicinal plants, we have 
previously identified eight isoquinoline alkaloids from C. dubia. Out of these, we report here on two of the major alkaloids, scoulerine (1) and cheilanthifoline 
(2) and their inhibitory activities against acetylcholinesterase (anti-AChE), tumor necrosis factor alpha (anti TNF-α) and a bacterial strain, Helicobacter pylori. 
Both alkaloids showed weak anti TNF-α and antibacterial activities. However, the anti-AChE activity of scoulerine (1) was promising as it significantly 
inhibited AChE with a minimum inhibitory requirement (MIR) value of 0.0015 nmol, which was two-fold better than the reference drug, galanthamine (MIR 
value of 0.003 nmol). As there are limited anti-Alzheimer’s chemotherapeutics, scoulerine (1) is worthy of further exploration, including lead optimization, 
structure-activity-relationship studies, analog development, pharmacodynamics and in vivo animal studies. 
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Historically, natural products have played an important role in 
traditional medicines and drug discoveries. Drugs discovered from 
natural sources, especially medicinal plants, continue to provide 
new drug lead compounds and also enter clinical trials, particularly 
as antimalarial, anticancer and antimicrobial agents. A detailed 
analysis of new medicines approved by the US Food and Drug 
Administration (FDA) between 1981 and 2010 revealed that 34% of 
those medicines that were based on small molecules were natural 
products or direct derivatives of natural products [1-2]. Medicinal 
plants belonging to the genus Corydalis (Family Papaveraceae) are 
known to contain drug-like bioactive isoquinoline alkaloids with 
promise for treating inflammation, microbial infections, cancers, 
and Alzheimer’s disease (AD) [3].  
 
As part of a wider program investigating Bhutanese medicinal 
plants, we have previously carried out phytochemical and biological 
activity studies of the three Bhutanese Corydalis species (C. 
calliantha, C. crispa and C. dubia), which resulted in the 
identification of number of isoquinoline alkaloids with potent 
antimalarial activity against the multidrug resistant Plasmodium 
falciparum strain [4-7]. The crude MeOH and CHCl3 extracts of C. 
dubia showed anti-inflammatory activity with 58% and 62% 
inhibition of TNF-α production, respectively, in LPS activated 
THP-1 cells [8]. Traditionally, this medicinal plant is indicated for 
treating impure blood (detox), fever arising from infections of the 
liver, heart, lung, pancreas and kidney, and in alleviating neuralgia 
and complicated disorders (combination of defective air, bile and 
phlegm) that bore relevance to the symptoms of inflammation, 
microbial infections and AD [4]. Considering these, we have further 
investigated two major isoquinoline alkaloids - scoulerine (1) and 
cheilanthifoline (2) (Figure 1) for their anti-inflammatory, anti-
bacterial and the anti-acetylcholinesterase (anti-AChE) activities. 
These two alkaloids are related since they are both biosynthesized 
in plants from tyrosine [9]. Protopine, one of the major alkaloids of 
this plant, is biosynthetically related to these two alkaloids and has 
shown broad-spectrum bioactivities, especially anti-inflammatory 
and AChE inhibitory activities [6,10-11]. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Structure of the two major isoquinoline alkaloids (isolated from C. dubia), 
which were tested for their anti-inflammatory, anti-bacterial and anti-
acetylcholinesterase activities.  
 
Our studies revealed that scoulerine (1) and cheilanthifoline (2) also 
possess broad-spectrum biological activities. Both these alkaloids 
exhibited weak antibacterial and anti-inflammatory properties, but 
showed strong –moderate anti-acetylcholinesterase activity (Table 
1). Plant derivatives are clinically known for their anti-
inflammatory properties [12]. Out of 171 alkaloids isolated between 
1907 and 2000, 137 were reported to have anti-inflammatory 
properties [13]. 
 
Table 1: Anti-AChE, anti-TNF-α and antibacterial activities of compounds 1 and 2 
from C. dubia. 
 
Compds/positive 
controls 
Anti-AChE* 
MIR (nmol) 
Anti-TNF-α** 
TNF-α   
(pg/mL)    % inhibition 
Antimicrobial*** 
H. pylori 
MIZ (mm)   MIC (µg/mL) 
MeOH extract 
1 
            0.0015 566 ± 17      − (9)    6                2000 
2             0.31 541 ± 33      − (13)    5                250 
Galanthamine
a
             0.003   
Dexamethasone
b
              258 ± 65      − (58)  
 
 
Cheilanthifoline (2) Scoulerine (1) 
 Wangchuk et al. 
1% DMSO/RPMI
c
                      620 ± 54     Vehicle   
Amoxicillin
d
       7               16  
−: inhibited; *Acetylcholinesterase inhibitory activity. **Anti-inflammatory activity 
with measurement of TNF-α (in pg/mL) when co-cultured with the test compounds and 
their % inhibition. ***Antimicrobial activity against H. pylori showing both minimum 
inhibition zone (MIZ) and minimum inhibitory concentrations (MIC). Compounds were 
tested against seven bacterial and one fungal strain and the result shows only the 
compound-susceptible strain. aReference drug for acetylcholinesterase activity. 
bReference drug for anti-inflammatory activity. c Vehicle control for anti-inflammatory 
assay. dReference drug for antimicrobial activity 
 
Corydalis species have been widely studied for their anti-
inflammatory isoquinoline alkaloids and many of them, especially 
tetrahydropalmatine (isolated from C. yanhusuo), pseudocoptisine 
(isolated from C. turtschaninovii) and ochotensimine (isolated from 
C. impatiens), significantly inhibited the production of IL-6, IL-8, 
TNF-α and also other mediators that are involved in the 
inflammation process [3]. In inflammatory diseases, the pro-
inflammatory cytokine, TNF-α, plays a central role in inflammation 
and autoimmune diseases. Thus, the pro-inflammatory cytokine 
(TNF-α) in bacterial lipopolysaccharide (LPS) activated THP-1 
cells are commonly used for evaluating the anti-inflammatory 
effects of various plant materials [6,14]. Using this model, we have 
earlier investigated the anti-inflammatory activity of the crude 
methanol extract of C. dubia and showed that it significantly 
inhibited the production of pro-inflammatory cytokine –TNF-α with 
62% inhibition, which appeared better than the positive control 
(dexamethasone) with 58% inhibition [8]. Encouraged by this, we 
have further investigated the anti-inflammatory activity of the two 
major compounds – scoulerine (1) and cheilanthifoline (2) – 
isolated from C. dubia. Both compounds exhibited only weak anti-
inflammatory activity (Table 1). Of the two compounds tested, 
cheilanthifoline (2) inhibited TNF-α cytokine production in LPS 
activated THP-1 cells by 13% in comparison with the solvent 
control (1% DMSO/RPMI). Since compounds 1 and 2 did not show 
significant anti-TNF-α activities, we believe that there may be some 
minor chemical components in the crude extract, which were lost 
during our isolation process. 
 
Corydalis species and their isoquinoline alkaloids have also 
demonstrated antimicrobial properties including antiviral, antifungal 
and antibacterial [3,15]. Li and co-workers studied in vitro anti-
Helicobacter pylori activity of 30 Chinese herbal medicines used 
for treating gastric ulcers in traditional medicine of China and 
discovered that the ethanolic extract of C. yanhusuo showed 
moderate antibacterial activity with a MIC value of 60 mg/mL [3]. 
Antimicrobial activity is assessed by both agar well diffusion (based 
on the zone of inhibition) and broth dilution (minimum inhibition 
concentration) methods. According to the broth dilution screening 
method for antimicrobial activity of higher plants, a prominent 
antibacterial effect worthy of further investigation is said to be as 
low as 1/32 dilutions-based inhibitory activities [16-17]. Rojas et al. 
[18] considered plant extracts and derivatives as bioactive 
antimicrobials if the MIZ is ≥3 mm well diameter. Svetaz et al. 
[19], Mohamad et al. [20] and Geyid et al. [21] reported plant 
extracts and their constituents as antimicrobial agents if their 
minimum inhibition concentrations (MIC) were in the range of 
1000 - 4000 µg/mL. This suggests that a researcher can set the 
criteria of antimicrobial activity depending upon their interest of 
microbial strains under investigation. In this study, we have 
interpreted the results of test compounds as inhibitory only if the 
MIZ was ≥5 mm well diameter or if their MIC was ≤300 µg/mL. 
Values below 5 mm well diameter or above 300 µg/mL were 
considered either as inactive or not showing inhibition. We first 
assessed the inhibition zones of scoulerine (1) and cheilanthifoline 
(2) against seven bacterial strains (Escherichia coli, Bacillus 
subtilis, Staphylococcus aureus, methicillin resistant S. aureus 
(MRSA), S. epidermidis, Vibrio cholerae, and Helicobacter pylori) 
and one yeast strain (Candida albicans), and then finally 
determined the MIC of the compounds that showed MIZs of ≥5 mm 
well diameter. While cheilanthifoline (2) showed the higher MIZ of 
6 mm against only B. subtilis and H. pylori, this activity did not 
translate proportionately when its MIC was determined (MIC = 
2000 µg/mL, not active). On the other hand, scoulerine (1) showed 
a MIZ of 5 mm against the H. pylori strain (Table 1) and 
demonstrated a better MIC value (250 µg/mL) in comparison with 
cheilanthifoline (2). The crude extracts of C. dubia, from which 
compounds 1 and 2 were isolated, exhibited weak antibacterial 
activity against S. aureus, MRSA, B. subtilis and S. epidermidis 
with MIZs of 5–6 mm [4]. Both alkaloids were inactive against the 
bacterial and yeast strains tested here. 
 
Corydalis species are known AChEIs [3,22]. Acetylcholinesterase 
(AChE) is responsible for the termination of nerve impulse 
transmission at the cholinergic synapses by rapid hydrolysis of 
acetylcholine (ACh), which is a neurotransmitter linked to 
Alzheimer's disease (AD). AD affects more than 20 million people 
every year and is increasing [23]. Drug discovery within the AD 
field has for the last 20 years been rather amyloidcentric and only 
recently have other mechanisms and targets for screening been 
considered, including ones connected to inflammation, oxidative 
stress and the mechanistic intervention approach by targeting 
neurotransmitter dysfunction. Inhibitors of AChE currently form the 
basis of drugs for the management of AD, including the alkaloid – 
galanthamine, which was isolated from Galanthus woronowii [24]. 
AChE inhibitors (AChEI) increase the availability of acetylcholine 
in central cholinergic synapses and improve memory and cognitive 
deficits of the patients by diminishing the breakdown of 
acetylcholine at the synaptic site in the brain [3, 22-23]. Various 
assay protocols to screen for AChEI exist [23,25] and the choice of 
an appropriate screening assay is crucial. Di Giovanni et al. [26] 
have compared two colorimetric screening assays frequently used to 
detect acetylcholinesterase inhibitory activity (Marston et al. [27] 
and Ellman et al. [28]) involving a test set of 138 compounds. They 
obtained similar results and concluded that both AChE inhibitory 
screening assays are suitable for the generation of new hits. In this 
study, we used the method described by Marston et al. [27] and 
interpreted the result as described in Sastruruji et al. [29]. The TLC 
plate loaded with varying concentrations of the test compounds was 
sprayed with AChE enzyme stock solution, which was prepared 
from acetylcholinesterase of electric eels (EC 3.1.1.7, 906 U/mg). 
Structures of the human recombinant and eel enzymes are very 
similar [23], but they cannot be considered as identical, nor will 
inhibitors as a rule give identical results. Of the two alkaloids 
tested, scoulerine (1) exhibited a highly significant AChE inhibitory 
activity at a 1 ng concentration with a minimum inhibitory 
requirement (MIR) value of 0.0015 nmol, which was two-fold 
better than the reference drug, galanthamine (1 ng) with a MIR 
value of 0.003 nmol (Table 1). Cahlikova et al. [30] earlier reported 
that this same compound exhibited anti-AChE activity with an IC50 
value of 245 µM against human AChE using the method described 
by Ellman et al. [28]. Obviously, the results of these two studies 
(ours versus Cahlikova et al. [30]) cannot be compared since 
different materials and methods were used, including target 
enzymes, colorimetric methods and the plant species. However, 
both these studies validated that scoulerine (1), though obtained 
from two different plant species (Eschscholzia californica and C. 
dubia), is a good AChEI. Cheilanthifoline (2) exhibited moderate 
AChE inhibitory activity with a MIR value of 0.31 nmol.  
 
In conclusion, our study showed that scoulerine (1) and 
cheilanthifoline (2) have broad-spectrum biological activities, such 
Bioactivities of scoulerine and cheilanthifoline   
as anti-inflammatory, antibacterial and anti-AChE. These findings 
validated the traditional uses of C. dubia in Bhutanese medicine. 
We also confirmed that scoulerine (1) is a good AChEI. This 
alkaloid is a simple, non-toxic, small molecule [7] and has the 
physio-chemical properties of drug-like compounds that meet the 
criteria of the Lipinski rule of 5 [31]. Considering this, scoulerine 
(1) is worthy of further exploration including lead optimization, 
structure-activity-relationship studies, analogue development, 
pharmacodynamics and in vivo animal studies.  
 
Experimental 
 
Plant materials and preparation of compounds for biological 
testing: Corydalia dubia Prain was collected, processed and 
chemically assessed, as previously described by us [7]. Briefly, 
alkaloids 1 and 2 (along with 6 other alkaloids, as described in 
Wangchuk et al. [7]) were obtained through acid-base fractionation 
of extracts focusing on the alkaloids and then repeatedly purified by 
column and preparative thin layer chromatography (PTLC). Final 
separation of the basic fraction using PTLC plates with a mobile 
phase - CHCl3/ethyl acetate (55:45 v/v) yielded scoulerine (1) and 
the other fraction furnished cheilanthifoline (2) (PTLC plate in a 
mobile phase of CHCl3/ethyl acetate/NH4OH) (55:45:4 drops). 
Stock solutions of these compounds were prepared in accordance to 
the requirements of different assay protocols. 
 
Anti-AChE activity assay: The AChE inhibitory activity of 
scoulerine (1) and cheilanthifoline (2) were determined using the 
rapid TLC bioautographic method described by Marston et al. [27] 
and Sastraruji et al. [29]. The TLC plates were washed with 
acetone, dried, and the test compounds applied to the plates in 
varying quantities. The plate was sprayed with AChE enzyme stock 
solution, which was prepared from acetylcholinesterase of electric 
eels (EC 3.1.1.7, 906 U/mg). The plates were incubated at 37°C for 
20 min and then sprayed with freshly prepared indicator solution 
(made from 1-naphthyl acetate and Fast Blue B salt to give the plate 
a purple coloration after 1-2 min); the compounds that inhibited 
AChE exhibited white spot on the plates. Galanthamine was used as 
a reference compound. The tests were performed in triplicate. 
 
Anti-inflammatory assay: This assay was performed as previously 
described [6,8,14]. Briefly, THP-1 human monocytic cell lines 
(ATCC, TIB 202) were maintained in RPMI 1640 (Gibco-
Invitrogen, USA) supplemented with 10% fetal bovine serum 
(Gibco-Invitrogen, USA) in tissue culture flasks (Corning, USA) 
and were incubated (37°C in humidified 5% CO2 incubator). For 
bioassays, cells were counted with a hemocytometer under an 
inverted microscope (Nikon TMS No. 300679: Nikon, Japan) and 
diluted to desired cell densities. THP-1 cells (200 µL) were seeded 
in 96-well tissue culture plates (Corning, USA) at a final density of 
2.5 x105 cells/mL. Cells were incubated with the compounds alone 
or in combination with purified LPS (100 ng/mL) from Escherichia 
coli serotype O127 : B8 (Sigma, USA) for 3.5 h. Supernatants were 
collected from individual wells by centrifugation and assayed for 
TNF-α. The cell viability of compounds in THP-1 cells was 
determined by the Trypan-blue (Gibco-Invitrogen, USA) stain 
exclusion assay. Cells were incubated with varying concentration of 
compounds (0, 1.95, 3.9, 7.8, 15.6 and 31.25 µg/mL). The cell 
suspension was mixed with Trypan Blue, which stained dead cells. 
The percentage of cell viability was calculated by the formula: % 
Cell viability = 100 × (1−(dead cells/total cells)). TNF-α production 
in THP-1 cell culture supernatants was measured using cytokine-
specific sandwich quantitative enzyme-linked immunosorbent 
assays (ELISAs) according to the manufacturer’s instructions (R & 
D Systems, USA). Recombinant human TNF-α was used as 
standard at concentrations of 15.6, 31.5, 62.5, 125, 250, 500, and 
1000 pg/mL. Absorbance was measured at 450 nm using a BioTek® 
Synergy™ HT (Multi-Detection Microplate Reader, USA). 
Cytokine concentration in each well was quantified from a standard 
curve and expressed as pg/mL of culture medium. A commercial 
anti-inflammatory drug, dexamethasone (10 µg/mL), (Atlantic 
LabsComp. Ltd., Thailand) was used as a positive control. The 
experiments were performed 3 times in triplicate. The percentage of 
TNF-α inhibition was calculated by the formula: % TNF-α 
inhibition = 100 × ((observed/baseline) − 1). Where observed = 
secreted TNF-α of experiment (pg/mL) and baseline = secreted 
TNF-α of DMSO (pg/mL).  
 
Antimicrobial test methods: The antimicrobial assay was 
performed as previously described [4,6,32]. Briefly, 7 bacterial 
strains (Escherichia coli (ATCC 25922), Bacillus subtilis (ATCC 
6633), Staphylococcus aureus (ATCC 6538), methicillin resistant S. 
aureus (MRSA), (DMST 20651), S. epidermidis (ATCC 12228), 
Vibrio cholerae (DMST 2873), and Helicobacter pylori (H40)) and 
on YEAST strain {Candida albicans (ATCC 10231)} were used for 
the study. C. albicans was grown on Sabouraud Dextrose Agar 
(SDA) (Becton Dickinson, USA) and incubated (25 °C, 24-48 h). H. 
pylori was grown on Brain Heart Infusion (BHI) agar (Becton 
Dickinson, USA) supplemented with horse serum (10%) (GIBCO 
Invitrogen, England) and incubated (at 37°C for 3 days) under 
micro-aerobic conditions (5% O2, 10% CO2, 85% N2) generated by 
using a micro-aerobic GasPak (Mitsubishi, Japan) in an anaerobic 
jar (Mitsubishi, Japan). Other bacterial strains were grown on 
Mueller Hinton Agar (MHA) (Becton Dickinson, USA) under 
aerobic conditions (37°C, 24 h). The inocula of test organisms were 
prepared in appropriate broth by adjusting to the McFarland 
standard. A modified agar well diffusion method (AWD) [33-34] 
was used for determining the minimum inhibition zones (MIZ in 
mm diameters) for each compound. The MIC was examined by the 
broth microdilution method, as described by Wayne [35]. A serial 
two-fold dilution of each compound prepared in 96-well microtiter 
plates (Corning, USA) (stock concentration of 3 mg/mL) was used 
for measuring the minimum inhibitory concentration (MIC). 
Amphotericin B (Sigma-Aldrich,USA), vancomycin (Edicin, 
Slovenia) and amoxicillin (Government Pharmaceutical 
Organization, Thailand) were used as reference drugs against the 
yeast, MRSA and other bacterial strains, respectively. DMSO and 
distilled water were used as controls. The experiments were 
performed 3 times in duplicate.    
  
Acknowledgments – We appreciate the Endeavour Award and the 
NHMRC Early Career Fellowship, which enabled PW to carry out 
the studies described here. Mr. Samten of Menjong Sorig 
Pharmaceuticals provided the plant materials.  
References 
[1] Harvey AL, Edrada-Ebel RA, Quinn RJ. (2015) The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug 
Discovery, 14, 111-129. 
[2] Newman DJ, Cragg GM. (2012) Natural products as sources of new drugs over the 30 years from 1980 to 2010. Journal of Natural Products, 75, 322-
335. 
[3] Iranshahy M, Quinn RJ, Iranshahi M. (2014) Biologically active isoquinoline alkaloids with drug-like properties from the genus Corydalis. RSC 
Advances, 4, 15900–15913. 
 Wangchuk et al. 
[4] Wangchuk P, Keller PA, Pyne SG, Taweechotipatr M, Tonsomboon A, Rattanajak R, Kamchonwongpaisan S. (2011) Evaluation of 
ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities. Journal of 
Ethnopharmacology, 137, 730−742. 
[5] Wangchuk P, Bremner JB, Samten, Rattanajak R, Kamchongpaisan S. (2010) Antiplasmodial agents from the Bhutanese medicinal plant Corydalis 
calliantha. Phytotherapy Research, 24, 481−485. 
[6] Wangchuk P, Keller PA, Pyne SG, Sastraruji T, Taweechotipatr M, Rattanajak R, Tonsomboon A, Kamchonwongpaisan S. (2012) Phytochemical and 
biological activity studies of the Bhutanese medicinal plant Corydalis crispa. Natural Product Communications, 7, 575-580. 
[7] Wangchuk P, Keller PA, Pyne SG, Willis AC, Kamchonwongpaisan S. (2012) Antimalarial alkaloids from a Bhutanese traditional medicinal plant 
Corydalis dubia. Journal of Ethnopharmacolology, 143, 310–313.  
[8] Wangchuk P, Keller PA, Pyne SG, Taweechotipatr M. (2013) Inhibition of TNF-α production in LPS-activated THP-1 monocytic cells by the crude 
extracts of seven Bhutanese medicinal plants. Journal of Ethnopharmacology, 148,1013-1017. 
[9] Takao N, Iwasa K, Kamigauchi M, Sugiura M. (1976) Studies on the alkaloids of Papaveraceous plants. XXV. Biosynthesis of alkaloids of Corydalis 
incisa Pers and Chelidonium majus L. Incorporations of tetrahydroprotoberberines, N-methosalts of tetrahydroprotoberberines, and protopine. 
Chemical & Pharmaceutical Bulletin, 24, 2859-2868. 
[10] Vacek J, Walterova D, Vrublova E, Simanek V. (2010) The chemical and biological properties of protopine and allocryptopine. Heterocycles, 81, 
1773−1789. 
[11] Saeed SA, Gilani AH, Majoo RU, Shah BH. (1997) Anti-thrombotic and anti-inflammatory activities of protopine. Pharmacological Research, 36, 
1−7. 
[12] Calixto JB, Campos MM, Otuki MF, Santos ARS. (2004). Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory 
cytokines, chemokines and adhesion molecules. Planta Medica, 70, 93-103. 
[13] Barbosa-Filho JM, Piuvezam MR, Moura MD, Silva MS, Lima KVB, da-Cunha EVL, Fechine IM, Takemura OS. (2006) Anti-inflammatory activity 
of alkaloids: A twenty-century review. Brazilian Journal of Pharmacognosy, 16, 109-139. 
[14] Taweechotipatr M, Iyer C, Spinler JK, Versalovic J, Tumwasorn S. (2009) Lactobacillus saerimneri and Lactobacillus ruminis: novel human derived 
probiotic strains with immunomodulatory activities. FEMS Microbiology Letters, 293, 65−72. 
[15] Opletal L, Locarek M, Frankova A, Chlebek J, Smid J, Hostalkova A, Safratova M, Hulcova D, Kloucek P, Rozkot M, Cahlikova L. (2014) 
Antimicrobial activity of extracts and isoquinoline alkaloids of selected Papaveraceae plants. Natural Products Communications, 9, 1709-1712.  
[16] Vanden-Berghe DA, Vlietinck AJ. (1991) Screening methods for antibacterial and antiviral agents from higher plants. In Methods in Plant 
Biochemistry. Assays for Bioactivity. Dey PM, Harborne JB, Hostettman K. (Eds). Academic Press, London, vol. 6, pp. 47–69. 
[17] Kokoska L, Polesny Z, Rada V, Nepovim A, Vanek T. (2002) Screening of some Siberian medicinal plants for antimicrobial activity. Journal of 
Ethnopharmacology, 82, 51–53. 
[18] Rojas A, Hernandez L, Pereda-Miranda R, Mata R. (1992) Screening for antimicrobial activity of crude drug extracts and pure natural products from 
Mexican medicinal plants. Journal of Ethnopharmacology, 35, 275–283. 
[19] Svetaz L, Zuljan F, Derita M, Petenatti E, Tamayo G, Caceres A, Filho VC, Gimenez A, Pinzon R, Zacchino SA, Gupta M. (2010) Value of the 
ethnomedical information for the discovery of plants with antifungal properties: a survey among seven Latin American countries. Journal of 
Ethnopharmacology, 127,137–158. 
[20] Mohamad S, Zin NM, Wahab HA, Ibrahim P, Sulaiman SF, Zahariluddin ASM, Noor SSM. (2011) Antituberculosis potential of some 
ethnobotanically selected Malaysian plants. Journal of Ethnopharmacology, 133, 1021–1026. 
[21] Geyid A, Abebe D, Debella A, Makonnen Z, Aberra F, Teka F, Kedede T, Urga K, Yersaw K, Biza T, Mariam BH, Guta M. (2005) Screening of 
some medicinal plants of Ethiopia for their antimicrobial properties and chemical profiles. Journal of Ethnopharmacology, 97, 421–427. 
[22] Chlebek J, Macakova K, Cahlikova L, Kurfurst M, Kunes J, Opletal L. (2011) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds 
from Corydalis cava (Fumariaceae). Natural Product Communications, 6, 607-610. 
[23]  Vasange M. (2014) Assay suitability for natural product screening: Searching for leads to fight Alzheimer’s disease. Planta Medica, 80, 1200-1209.  
[24] Fulton B, Benfield P. (1996) Galanthamine. Drugs & Aging, 9, 60-67. 
[25]  Dewanjee S, Gangopadhyay M, Battacharya N, Khanra R, Dua TK. (2015) Bioautography and its scope in the field of natural product chemistry. 
Journal of Pharmaceutical Analysis, 5, 75-84. 
[26] Di Giovanni S, Borloz A, Urbain A, Marston A, Hostettmann K, Carrupt PA, Reist M. (2008) In vitro screening assays to identify natural or synthetic 
acetylcholinesterase inhibitors: Thin layer chromatography versus microplate methods. European Journal of Pharmaceutical Sciences, 33, 109-119. 
[27] Marston A, Kissling J, Hostettmann K. (2002) A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase 
inhibitors in plants. Phytochemical Analysis, 13, 51–54. 
[28] Ellman GL, Courtney D, Andres Jr. V, Featherstone RM. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. 
Biochemical Pharmacology, 7, 88–95. 
[29]  Sastraruji K, Sastraruji T, Pyne SG, Ung AT, Jatisatienr A, Lie W. (2010) Semisynthesis and acetylcholinesterase inhibitory activity of stemofoline 
alkaloids and analogues. Journal of Natural Products, 73, 935-941. 
[30] Cahlikova L, Macakova K, Kunes J, Kurfurst M, Opletal L, Cvacka J, Chlebek J, Blunden G. (2010) Acetylcholinesterase and butyrylcholinesterase 
inhibitory compounds from Eschscholzia californica (Papaveraceae). Natural Product Communications, 5, 1035-1038. 
[31] Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001) Experimental and computational approaches to estimate solubility and permeability in 
drug discovery and development settings. Advance Drug Delivery Reviews, 46, 3-26. 
[32]  Wangchuk P, Pyne SG, Keller PA,Taweechotipatr M, Kamchonwongpaisan S. (2014). Phenylpropanoids and furanocoumarins as antibacterial and 
antimalarial constituents of the Bhutanese medicinal plant, Pleurospermum amabile. Natural Product Communications, 8, 1305-1308. 
[33] Perez C, Paul M, Bazerque P. (1990) An antibiotic assay by the agar well diffusion method. Acta Biologiae at Medecine Experimentalis, 15, 113-115. 
[34] Mattana CM,  Satorres SE, Sosa A,  Fusco M, Alcaráz LE. (2010) Antibacterial activity of extracts of Acacia aroma against methicillin-resistant and 
methicillin-sensitive Staphylococcus. Brazilian Journal of Microbiology, 41, 581-587. 
[35] Goyal P, Chauhan A, Kaushik P. (2009) Laboratory evaluation of crude extracts of Cinnamomum tamala for potential antibacterial activity. Electronic 
Journal of Biology, 5, 75-79. 
